Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Withdrawn × Neuroma × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 111 Carcinoma, Non-Small-Cell Lung 102 Prostatic Neoplasms 63 Neoplasm Metastasis 63 Multiple Myeloma 63 Colorectal Neoplasms 63 Neoplasms 59 Lung Neoplasms 50 Leukemia, Myeloid, Acute 41 Carcinoma, Hepatocellular 41 Recurrence 40 Lymphoma 40 Leukemia, Lymphocytic, Chronic, B-Cell 36 Melanoma 34 Pancreatic Neoplasms 33 Head and Neck Neoplasms 26 Glioblastoma 26 Rectal Neoplasms 25 Ovarian Neoplasms 25 Lymphoma, Large B-Cell, Diffuse 25 Leukemia 24 Brain Neoplasms 24 Squamous Cell Carcinoma of Head and Neck 23 Hematologic Neoplasms 23 Carcinoma, Renal Cell 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Myelodysplastic Syndromes 20 Colonic Neoplasms 20 Lymphoma, Non-Hodgkin 19 Uterine Cervical Neoplasms 18

Interventions

Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡